Clinical Trial: Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Phase 1 Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma

Brief Summary: This phase I trial studies the side effects and best dose of panobinostat in treating younger patients with diffuse intrinsic pontine glioma that is growing, spreading, or getting worse (progressive). Panobinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.